Though Organovo produced 3D printed kidney cells earlier this year, last week, Professor Melissa Little‘s research team at the University of Queensland (UQ)’s Institute for Molecular Bioscience demonstrated the ability to create a complete miniature kidney. Now, however, the two are teaming up to create a mutually beneficial relationship, both for the partners involved and the world at large. Today, Organovo has signed an exclusive worldwide licensing agreement with UniQuest, the technology transfer and commercialization company of UQ, to patent applications related these kidney cells, developed from induced pluripotent stem cells (iPSCs).
3D printers can increasingly be found in hospitals all over the world, and are especially used by build surgical models to prepare for very unusual and highly complex surgeries. Back in April, the life of […]
The applications for 3D printing in the medical industry highlight the technology’s transformative power more clearly than those in other industries while promising to impact the lives of millions of patients. Recent groundbreaking achievements will […]
One of the most scientifically mind-blowing materials ever discovered, graphene (an allotrope of carbon) has been praised for having an unbelievable combination of material characteristics, including low density, top-notch mechanical properties, thermal stability, and even […]